These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 6689459)
1. [Results of polychemotherapy (a VMCP/VCAP program) in multiple myeloma]. Wutke K; Anger G Z Gesamte Inn Med; 1983 Dec; 38(23):630-3. PubMed ID: 6689459 [TBL] [Abstract][Full Text] [Related]
2. [The efficacy of polychemotherapy programs in treating multiple myeloma patients]. Bessmel'tsev SS; Abdulkadyrov KM; Rukavitsyn OA Ter Arkh; 1998; 70(7):46-9. PubMed ID: 9742636 [TBL] [Abstract][Full Text] [Related]
4. Combined alpha-2C-interferon/VMCP polychemotherapy versus VMCP polychemotherapy as induction therapy in multiple myeloma: a prospective randomized trial. Scheithauer W; Cortelezzi A; Fritz E; Kührer I; Polli E; Baldini L; Ludwig H J Biol Response Mod; 1989 Apr; 8(2):109-15. PubMed ID: 2659740 [TBL] [Abstract][Full Text] [Related]
5. [Heterogenicity of the response to chemotherapy in plasmablastic myeloma]. Paule B; Quillard J; Bisson M; Massias P Nouv Rev Fr Hematol (1978); 1987; 29(6):391-6. PubMed ID: 2454453 [TBL] [Abstract][Full Text] [Related]
6. Comparison of melphalan and prednisone with vincristine, carmustine, melphalan, cyclophosphamide, and prednisone in the treatment of multiple myeloma: results of Eastern Cooperative Oncology Group Study E2479. Oken MM; Harrington DP; Abramson N; Kyle RA; Knospe W; Glick JH Cancer; 1997 Apr; 79(8):1561-7. PubMed ID: 9118039 [TBL] [Abstract][Full Text] [Related]
7. [Results of treatment of patients with advanced multiple myeloma with the vincristine-adriamycin-dexamethasone protocol]. Marisavljević D; Bosković D; Radosević N; Elezović I; Tomin D; Gotić M; Antunović P Srp Arh Celok Lek; 1996; 124(11-12):292-6. PubMed ID: 9132962 [TBL] [Abstract][Full Text] [Related]
8. The addition of interferon or high dose cyclophosphamide to standard chemotherapy in the treatment of patients with multiple myeloma: phase III Eastern Cooperative Oncology Group Clinical Trial EST 9486. Oken MM; Leong T; Lenhard RE; Greipp PR; Kay NE; Van Ness B; Keimowitz RM; Kyle RA Cancer; 1999 Sep; 86(6):957-68. PubMed ID: 10491521 [TBL] [Abstract][Full Text] [Related]
9. [Clinical trial of alpha-interferon (human lymphoblastoid interferon) in combination with VCAP chemotherapy in multiple myeloma]. Umeda M; Shirai T; Tsukahara T; Kaneko H; Yamauchi M; Arai N; Kosuge T; Kato M; Shikoshi K; Anno S Rinsho Ketsueki; 1991 Jun; 32(6):669-74. PubMed ID: 1890744 [TBL] [Abstract][Full Text] [Related]
10. [Relationship between prognosis of multiple myeloma and response to VCAP therapy]. Umeda M; Annoh S; Takata M; Shikoshi K; Katoh M; Shirai T Rinsho Ketsueki; 1994 Mar; 35(3):272-8. PubMed ID: 8158848 [TBL] [Abstract][Full Text] [Related]
11. [Combined treatment, polychemotherapy and amino-hydroxybutylidene-diphosphonate, of a patient with multiple myeloma: remission and long survival]. Attardo-Parrinello G; Merlini G; Crema F; Fiorentini ML; Mazzone A; Cotti-Piccinelli E Medicina (Firenze); 1988; 8(3):318-20. PubMed ID: 3231044 [No Abstract] [Full Text] [Related]
12. [Combination chemotherapy with vincristine, melphalan, CCNA, cyclophosphamide, prednisone in myeloma]. Le Loët X; Monconduit M; Menard JF; Deshayes P; Grobois B; Tanguy A; Prevost E; Piguet H Rev Rhum Mal Osteoartic; 1984 May; 51(5):263-7. PubMed ID: 6740189 [TBL] [Abstract][Full Text] [Related]
13. Results and further perspectives of plasmocytoma chemotherapy. Sakalová A; Hrubisko M; Gazová S; Steruská M; Prümmerová J Neoplasma; 1986; 33(2):251-8. PubMed ID: 3520353 [TBL] [Abstract][Full Text] [Related]
14. [Results with the use of the M-2 protocol in plasmacytoma]. Ho AD; Wittkamp S; Theml H; Keilholz U; Hunstein W Dtsch Med Wochenschr; 1986 May; 111(22):858-61. PubMed ID: 3754811 [TBL] [Abstract][Full Text] [Related]
15. Therapy for multiple myeloma with alternating non-cross-resistant chemotherapy combinations: heterogeneity of tumor responsiveness. Morstyn G; Schechter GP; Ihde DC; Carney DN; Eddy JL; Cohen MH; Minna JD; Bunn PA Cancer Treat Rep; 1984 Dec; 68(12):1439-46. PubMed ID: 6391662 [TBL] [Abstract][Full Text] [Related]
16. [Recent therapy for refractory myeloma]. Togawa A Rinsho Ketsueki; 1993 Apr; 34(4):450-4. PubMed ID: 8510332 [TBL] [Abstract][Full Text] [Related]
17. Chemotherapy is superior to sequential hemibody irradiation for remission consolidation in multiple myeloma: a Southwest Oncology Group study. Salmon SE; Tesh D; Crowley J; Saeed S; Finley P; Milder MS; Hutchins LF; Coltman CA; Bonnet JD; Cheson B J Clin Oncol; 1990 Sep; 8(9):1575-84. PubMed ID: 2131793 [TBL] [Abstract][Full Text] [Related]
18. [Treatment of multiple myeloma using vincristine, cyclophosphamide, melphalan and prednisone (VCMP). Long-term results in 63 patients]. Bladé J; Urbano A; López Guillermo A; Rozman M; Rovira M; Montserrat E; Rozman C Sangre (Barc); 1990 Apr; 35(2):93-7. PubMed ID: 2363100 [TBL] [Abstract][Full Text] [Related]
19. Melphalan-prednisolone and vincristine-doxorubicin-dexamethasone chemotherapy followed by prednisolone/interferon maintenance therapy for multiple myeloma: Japan Clinical Oncology Group Study, JCOG0112. Chou T; Tobinai K; Uike N; Asakawa T; Saito I; Fukuda H; Mizoroki F; Ando K; Iida S; Ueda R; Tsukasaki K; Hotta T; Jpn J Clin Oncol; 2011 Apr; 41(4):586-9. PubMed ID: 21247967 [TBL] [Abstract][Full Text] [Related]
20. [Interferon in the treatment of multiple myeloma]. Kuzmits R; Ludwig H; Cortelezzi A; Van Camp BG; Polli E; Flener R; Scheithauer W Acta Med Austriaca; 1985; 12(5):135-8. PubMed ID: 3914174 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]